molecular formula C10H10N4O2S B1682646 Sulfadiazine CAS No. 68-35-9

Sulfadiazine

Cat. No.: B1682646
CAS No.: 68-35-9
M. Wt: 250.28 g/mol
InChI Key: SEEPANYCNGTZFQ-UHFFFAOYSA-N
Attention: For research use only. Not for human or veterinary use.
In Stock
  • Click on QUICK INQUIRY to receive a quote from our team of experts.
  • With the quality product at a COMPETITIVE price, you can focus more on your research.

Description

Historical Context of Sulfonamide Discovery and Development

The advent of sulfonamide drugs heralded the era of systemic antibacterial chemotherapy, providing the first broadly effective agents against bacterial infections wikipedia.orgfishersci.ie. The journey began in 1932 at the Bayer Laboratories, then part of the German chemical conglomerate IG Farben, under the leadership of German pathologist and bacteriologist Gerhard Domagk wikipedia.orguni.luwikipedia.orgmims.comfishersci.nouni.lu. Domagk's team was exploring azo dyes for their potential antibacterial properties uni.luwikipedia.orguni.lu.

Their research led to the discovery of Prontosil (sulfamidochrysoidine), a red azo dye, which demonstrated remarkable efficacy against streptococcal infections in mice uni.luwikipedia.orgmims.comuni.luguidetopharmacology.orgfishersci.cactdbase.org. Domagk published his groundbreaking findings in 1935, showcasing Prontosil's ability to treat streptococcal infections in both animals and humans uni.lumims.comuni.luguidetopharmacology.orgfishersci.ca. This discovery was a crucial initial step in combating bacterial diseases guidetopharmacology.org.

A pivotal development followed in late 1935 when French researchers at the Pasteur Institute, including Jacques and Thérèse Tréfouël, Daniel Bovet, and Federico Nitti, revealed that Prontosil itself was a prodrug; its antimicrobial activity stemmed from its metabolic conversion within the body to a simpler, colorless molecule: sulfanilamide wikipedia.orgwikipedia.orguni.luguidetopharmacology.org. Although sulfanilamide had been synthesized as early as 1906, its therapeutic potential as an antimicrobial agent was not recognized until the late 1930s wikipedia.orgnih.gov. Domagk's pioneering work earned him the 1939 Nobel Prize in Physiology or Medicine uni.luwikipedia.orgmims.comuni.luwikipedia.org. The introduction of sulfonamides laid the groundwork for the subsequent antibiotic revolution in medicine wikipedia.orgmims.com.

Sulfadiazine's Position within the Sulfonamide Class

Sulfonamides are a significant class of synthetic antimicrobial drugs characterized by the presence of a sulfanilamide group, containing the -SO₂NH₂ and/or -SO₂NH- functional group fishersci.ienih.govciteab.comnih.gov. These compounds are derivatives of para-aminobenzenesulfonamide (sulfanilamide) fishersci.ieciteab.comnih.govwikipedia.org.

This compound is a well-established sulfonamide antibiotic fishersci.ptwikipedia.orgnih.govhsnstore.eu. Structurally, it is defined by a pyrimidine ring with a 4-aminobenzenesulfonamido group positioned at the 2-position fishersci.pt. Its IUPAC name is 4-amino-N-pyrimidin-2-ylbenzenesulfonamide fishersci.ptwikipedia.org. This compound is one of several important sulfonamide derivatives developed, alongside compounds such as sulfamethazine, sulfamethoxazole, sulfasalazine, sulfisoxazole, and sulfamerazine nih.govnih.gov. The chemical distinctions between various sulfonamides, such as the presence of an extra dimethyl group in the pyrimidine ring of sulfamethazine compared to this compound, contribute to their differing properties and applications nih.gov. Generally, sulfonamides, including this compound, exert a bacteriostatic effect, meaning they inhibit the growth and multiplication of bacteria rather than directly killing them nih.govnih.govciteab.comwikipedia.orgnih.govhsnstore.eunih.govwikipedia.orguni.lu.

Overview of this compound's Mechanism of Action

This compound, like other sulfonamide antibiotics, exerts its antimicrobial effect primarily by interfering with the bacterial synthesis of folic acid (also known as folate or pteroylglutamic acid) fishersci.ienih.govnih.govciteab.comwikipedia.orgwikipedia.orgnih.govnih.govwikipedia.orguni.lunih.govwikipedia.orguni.lu. This mechanism targets a metabolic pathway that is essential for bacterial survival but is absent in humans.

The core of this compound's action lies in its role as a competitive inhibitor of the bacterial enzyme dihydropteroate synthase (DHPS, EC 2.5.1.15) fishersci.ienih.govciteab.comnih.govwikipedia.orgfishersci.ptwikipedia.orgnih.govnih.govwikipedia.orguni.lunih.govwikipedia.orguni.lu. DHPS is critical for the initial step in bacterial folic acid synthesis, catalyzing the incorporation of para-aminobenzoic acid (PABA) into dihydropteroic acid fishersci.ienih.govciteab.comnih.govwikipedia.orgfishersci.ptnih.govnih.govwikipedia.orguni.lunih.govwikipedia.orguni.lu. This compound's structural similarity to PABA allows it to bind to the active site of DHPS, effectively competing with PABA and preventing the enzyme from performing its natural function nih.govciteab.comnih.govnih.govwikipedia.org.

By inhibiting DHPS, this compound disrupts the production of dihydropteroic acid, thereby preventing the subsequent synthesis of folic acid within the bacterial cell fishersci.ienih.govnih.govciteab.comwikipedia.orgwikipedia.orgnih.govnih.govwikipedia.orguni.lunih.govwikipedia.orguni.lu. Folic acid is an indispensable coenzyme for bacteria, required for the synthesis of nucleic acids (DNA and RNA), as well as purines and pyrimidines nih.govnih.govciteab.comnih.govnih.govnih.govwikipedia.org. These molecules are fundamental building blocks necessary for bacterial growth, replication, and cell division nih.govnih.govnih.govwikipedia.org. The depletion of folic acid leads to a deficiency in these essential precursors, ultimately halting bacterial proliferation nih.govnih.govwikipedia.org.

Properties

IUPAC Name

4-amino-N-pyrimidin-2-ylbenzenesulfonamide
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

InChI

InChI=1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14)
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

InChI Key

SEEPANYCNGTZFQ-UHFFFAOYSA-N
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Canonical SMILES

C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Molecular Formula

C10H10N4O2S
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

DSSTOX Substance ID

DTXSID7044130
Record name Sulfadiazine
Source EPA DSSTox
URL https://comptox.epa.gov/dashboard/DTXSID7044130
Description DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.

Molecular Weight

250.28 g/mol
Source PubChem
URL https://pubchem.ncbi.nlm.nih.gov
Description Data deposited in or computed by PubChem

Physical Description

Solid
Record name Sulfadiazine
Source Human Metabolome Database (HMDB)
URL http://www.hmdb.ca/metabolites/HMDB0014503
Description The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.
Explanation HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.

Solubility

6.01e-01 g/L
Record name Sulfadiazine
Source DrugBank
URL https://www.drugbank.ca/drugs/DB00359
Description The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.
Explanation Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)
Record name Sulfadiazine
Source Human Metabolome Database (HMDB)
URL http://www.hmdb.ca/metabolites/HMDB0014503
Description The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.
Explanation HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.

CAS No.

68-35-9
Record name Sulfadiazine
Source CAS Common Chemistry
URL https://commonchemistry.cas.org/detail?cas_rn=68-35-9
Description CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.
Explanation The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.
Record name Sulfadiazine [USP:INN:BAN:JAN]
Source ChemIDplus
URL https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000068359
Description ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.
Record name Sulfadiazine
Source DrugBank
URL https://www.drugbank.ca/drugs/DB00359
Description The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.
Explanation Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)
Record name sulfadiazine
Source DTP/NCI
URL https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=757324
Description The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.
Explanation Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.
Record name sulfadiazine
Source DTP/NCI
URL https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=35600
Description The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.
Explanation Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.
Record name Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-
Source EPA Chemicals under the TSCA
URL https://www.epa.gov/chemicals-under-tsca
Description EPA Chemicals under the Toxic Substances Control Act (TSCA) collection contains information on chemicals and their regulations under TSCA, including non-confidential content from the TSCA Chemical Substance Inventory and Chemical Data Reporting.
Record name Sulfadiazine
Source EPA DSSTox
URL https://comptox.epa.gov/dashboard/DTXSID7044130
Description DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.
Record name Sulfadiazine
Source European Chemicals Agency (ECHA)
URL https://echa.europa.eu/substance-information/-/substanceinfo/100.000.623
Description The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness.
Explanation Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.
Record name SULFADIAZINE
Source FDA Global Substance Registration System (GSRS)
URL https://gsrs.ncats.nih.gov/ginas/app/beta/substances/0N7609K889
Description The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.
Explanation Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.
Record name Sulfadiazine
Source Human Metabolome Database (HMDB)
URL http://www.hmdb.ca/metabolites/HMDB0014503
Description The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.
Explanation HMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.

Mechanistic Insights into Sulfadiazine's Biological Activity

Inhibition of Dihydropteroate Synthetase (DHPS)

The core of sulfadiazine's antibacterial activity lies in its ability to inhibit the enzyme dihydropteroate synthetase (DHPS), a crucial component of the bacterial folic acid synthesis pathway.

Competitive Inhibition of p-Aminobenzoic Acid (PABA) in Folic Acid Synthesis Pathway

This compound functions as a competitive inhibitor of the bacterial enzyme dihydropteroate synthetase (DHPS). drugbank.comtoku-e.compatsnap.compatsnap.comncats.iodrugbank.compatsnap.comwisdomlib.orgnih.gov This inhibition occurs because this compound structurally resembles p-aminobenzoic acid (PABA), a natural substrate for DHPS. patsnap.compatsnap.comncats.iodrugbank.compatsnap.comwisdomlib.orgnih.gov By mimicking PABA, this compound competes for the active site of the DHPS enzyme, thereby preventing the enzyme from incorporating PABA into dihydropteroate. patsnap.compatsnap.comncats.iodrugbank.compatsnap.comwisdomlib.org This blocked reaction is a necessary step in the synthesis of folic acid within these microorganisms. drugbank.comtoku-e.comncats.iodrugbank.compatsnap.com

Essentiality of Folic Acid Synthesis for Bacterial Growth and Metabolism

Folic acid, specifically its active form tetrahydrofolate (THF), is an indispensable cofactor for enzymes involved in one-carbon metabolism within bacteria. nih.govfiveable.menih.govasm.orgresearchgate.netnih.gov This metabolic pathway is vital for the synthesis of critical cellular components, including nucleotides (the fundamental building blocks of DNA and RNA), purines, pyrimidines, and certain amino acids such as methionine, serine, and glycine. patsnap.compatsnap.compatsnap.comnih.govfiveable.measm.orgresearchgate.netnih.gov Furthermore, N-formylmethionine, derived from folate, is essential for the initiation of bacterial protein translation. asm.org

Unlike humans, who acquire folic acid from dietary sources, most bacteria must synthesize it de novo. patsnap.compatsnap.compatsnap.comnih.gov This fundamental difference renders the bacterial folic acid synthesis pathway an excellent and selective target for antibacterial agents like this compound. patsnap.com The disruption of folic acid production by this compound consequently impairs bacterial DNA, RNA, and protein synthesis, leading to the inhibition of their growth and proliferation. patsnap.compatsnap.compatsnap.com It is important to note that this compound is primarily bacteriostatic, meaning it inhibits the growth and multiplication of bacteria rather than directly killing them, thus relying on the host's immune system to eliminate the inhibited pathogens. patsnap.compatsnap.comwikipedia.org

Broader Antimicrobial Spectrum and Specificity

This compound, as a sulfonamide antibiotic, exhibits a broad spectrum of antimicrobial activity. drugbank.comncats.io This broad activity extends to a range of both Gram-positive and Gram-negative bacteria. drugbank.comncats.io Silver this compound, a related compound often used topically, also demonstrates broad antimicrobial activity against various bacteria and yeast. drugbank.compatsnap.comtaylorandfrancis.comnih.govpfizer.commdpi.compfizermedicalinformation.com

Activity Against Gram-Positive Bacteria (e.g., Staphylococcus aureus, Streptococcus pneumoniae)

This compound is effective against a majority of Gram-positive cocci. wisdomlib.org This includes notable pathogens such as Staphylococcus aureus and Streptococcus pneumoniae. taylorandfrancis.compfizer.compfizermedicalinformation.comwoundsinternational.comasm.org In in vitro testing, silver this compound has shown high sensitivity against Staphylococcus aureus, with 100 out of 101 tested strains being sensitive at concentrations of 50 µg/mL and 100 µg/mL. pfizer.compfizermedicalinformation.com Similarly, β-Hemolytic Streptococcus strains (4 out of 4 tested) demonstrated sensitivity to silver this compound at these concentrations. pfizermedicalinformation.com

Activity Against Gram-Negative Bacteria (e.g., Escherichia coli, Pseudomonas aeruginosa, Enterobacter, Klebsiella)

This compound demonstrates efficacy against numerous Gram-negative bacteria. drugbank.comncats.iowisdomlib.org This includes common pathogens such as Escherichia coli, Pseudomonas aeruginosa, Enterobacter species, and Klebsiella species. drugbank.comwisdomlib.orgtaylorandfrancis.compfizer.compfizermedicalinformation.comasm.orgnih.gov In vitro studies with silver this compound have shown high rates of sensitivity among these bacteria. For instance, 130 out of 130 Pseudomonas aeruginosa strains, 63 out of 63 Escherichia coli strains, 48 out of 50 Enterobacter species strains, and 53 out of 54 Klebsiella species strains were sensitive to silver this compound at a concentration of 50 µg/mL. pfizer.compfizermedicalinformation.com

Table 1: In Vitro Sensitivity of Bacterial Strains to Silver this compound (50 µg/mL)
Genus & SpeciesNumber of Sensitive Strains / Total Tested
Pseudomonas aeruginosa130/130
Escherichia coli63/63
Enterobacter species48/50
Klebsiella species53/54
Staphylococcus aureus100/101
β-Hemolytic Streptococcus4/4

Efficacy against Yeast (Candida albicans)

Silver this compound has shown moderate activity against yeast, including Candida albicans. drugbank.comtaylorandfrancis.compfizer.commdpi.compfizermedicalinformation.com Research indicates that sulfonamide drugs, including this compound, can exhibit synergistic activity when combined with azole antifungals against azole-resistant Candida albicans strains. contagionlive.com While silver this compound has demonstrated effectiveness in reducing bacterial bioburden in polymicrobial infections involving Pseudomonas aeruginosa and Candida albicans, its efficacy in reducing C. albicans proliferation may be less pronounced, suggesting that additional antifungal treatments might be necessary for complete eradication of Candida infections. researchgate.netwounds-uk.comoup.com

Activity against Parasitic Organisms (Toxoplasma gondii, Plasmodium falciparum)

This compound demonstrates significant activity against various parasitic organisms, notably Toxoplasma gondii and Plasmodium falciparum.

In the context of Toxoplasmosis , this compound is a cornerstone therapy, frequently administered in combination with pyrimethamine. Its antiparasitic action stems from the inhibition of dihydropteroate synthase (DHPS), an enzyme critical for the de novo folate biosynthesis pathway in T. gondii. This interruption of folate synthesis subsequently blocks the production of nucleic acids, which are vital for parasite survival and replication asm.orgmdpi.compatsnap.commedscape.com. Studies have indicated that this compound treatment can mitigate metabolic disturbances induced by T. gondii infection and may promote the differentiation of tachyzoites into bradyzoite-containing cysts asm.org. While effective, the development of resistance in T. gondii has been linked to mutations within the DHPS gene mdpi.comnih.gov.

Against Plasmodium falciparum , the causative agent of malaria, this compound functions as an antifolate by competitively inhibiting the parasite's dihydropteroate synthase (DHPS), thereby obstructing DNA synthesis nih.govbiorxiv.org. This mechanism is characteristic of sulfa drugs, which interfere with the folate metabolism cycle by acting as competitive inhibitors of p-aminobenzoic acid (PABA) nih.govdrugbank.com. This compound exhibits selective toxicity, effectively killing actively replicating asexual blood stages of Plasmodium parasites while sparing non-replicating gametocytes. This differential effect has led to its use as a tool for enriching gametocyte samples in rodent malaria models nih.govbiorxiv.orgnih.gov. However, this compound treatment has been shown to significantly impact host-to-vector transmission of the parasite nih.govbiorxiv.orgnih.gov. Investigations into metal complexes of this compound, such as the Fe(III) complex, suggest they may exhibit enhanced activity against resistant strains of P. falciparum compared to this compound alone ajol.info.

Cellular and Subcellular Targets Beyond DHPS

Beyond its primary role in inhibiting DHPS, this compound has been found to exert effects on various cellular and subcellular targets, particularly those involved in inflammatory processes.

This compound's Impact on Inflammatory Mediators and Enzymes (e.g., TNFα, IL1b, COX-1, COX-2, 5-LOX)

This compound demonstrates an anti-inflammatory effect by modulating the levels of key inflammatory mediators and enzymes. Research indicates its capacity to suppress the inflammatory response at a molecular level by influencing the expression of inflammation-related genes, including Tumor Necrosis Factor alpha (TNFα), Interleukin 1 beta (IL-1β), Cyclooxygenase-1 (COX-1), Cyclooxygenase-2 (COX-2), and 5-Lipoxygenase (5-LOX) mdpi.comnih.govdntb.gov.uaresearchgate.netnih.gov. Specifically, this compound has been shown to exhibit inhibitory activity against COX-1, COX-2, and 5-LOX enzymes nih.govnih.gov.

Molecular Modeling and Simulation Studies of Binding Interactions

Molecular modeling and simulation studies have provided valuable insights into the binding interactions of this compound with various targets, including COX-1, COX-2, and 5-LOX. Computational analyses, such as molecular docking and dynamics simulations, have revealed the key binding interactions that explain the activity profiles of this compound mdpi.comnih.govdntb.gov.uanih.govresearchgate.net. This compound exhibits a docking pattern within the COX-2 active site that is comparable to that of the reference drug celecoxib mdpi.com. Similarly, in the COX-1 active site, its docking pose resembles that of celecoxib and the crystallized inhibitor mofezolac mdpi.com. The 2-sulfamoylamino pyrimidine group of this compound has been identified as a crucial binding moiety, participating in interactions across all three investigated targets: COX-1, COX-2, and 5-LOX mdpi.com. Molecular dynamics simulations further support the robust stability of these interaction profiles mdpi.comresearchgate.netresearchgate.netfrontiersin.org.

Differential Inhibitory Activity against COX/LOX Pathway

This compound exhibits a distinct and balanced inhibitory activity profile against the Cyclooxygenase (COX) and Lipoxygenase (LOX) pathways. Experimentally, this compound has demonstrated a COX-2/COX-1 selectivity ratio of 3.6, which is higher than that observed for celecoxib (2.9) mdpi.com. While this compound shows weaker inhibitory activity against COX-2 (IC50 = 5.27 μM) compared to the selective COX-2 inhibitor celecoxib (IC50 = 1.94 μM), it presents a more balanced inhibitory effect across the COX/LOX pathway nih.govresearchgate.netnih.gov. Notably, this compound exhibits a greater affinity towards 5-LOX (IC50 = 19.1 μM) compared to COX-1 (IC50 = 18.4 μM) nih.govresearchgate.netnih.gov. This indicates that its activity profile favors 5-LOX inhibition at the expense of COX-1 inhibition, suggesting a balanced inhibitory action against the 5-LOX/COX-1 enzymes mdpi.comnih.govdntb.gov.uanih.gov.

Table 1: Experimental IC50 Values and Selectivity Ratios for this compound and Celecoxib against COX-1, COX-2, and 5-LOX mdpi.comnih.govnih.gov

CompoundCOX-1 IC50 (µM)COX-2 IC50 (µM)5-LOX IC50 (µM)COX-2/COX-1 Selectivity5-LOX/COX-1 Selectivity
This compound18.45.2719.13.61.0
Celecoxib5.91.9416.72.90.3

Note: IC50 values represent the half-maximal inhibitory concentration. Selectivity ratios are calculated as IC50(COX-1)/IC50(COX-2) and IC50(COX-1)/IC50(5-LOX) respectively.

Advanced Research on Sulfadiazine Derivatives and Synergistic Interactions

Rational Design and Synthesis of Novel Sulfadiazine Derivatives

The synthesis of novel this compound derivatives is a key area of research, focusing on modifying its structure to enhance biological activities and broaden its spectrum of action. These modifications often involve incorporating different chemical moieties onto the this compound scaffold.

Heterocyclic Compounds Bearing this compound Moiety

The incorporation of heterocyclic rings into the this compound structure has yielded promising results in developing new compounds with improved biological activities. Researchers have synthesized new series of ether and thioether derivatives of this compound by reacting this compound with chloroacetyl chloride, followed by treatment with various phenols and thiols. These synthesized derivatives have demonstrated superior antibacterial activity against both Gram-positive and Gram-negative bacteria, including strains like Candida albicans, when compared to established antibiotics such as amoxicillin and ciprofloxacin. uobaghdad.edu.iq

Another approach involves the synthesis of N-substituted this compound derivatives featuring different heterocyclic rings, such as 4-oxo-1,4-dihydroquinazolin and 4-oxo-2H-benzo uobaghdad.edu.iqCurrent time information in Bangalore, IN.thiazin. These compounds have been synthesized via condensation reactions and characterized using spectroscopic techniques like FT-IR, 1H-NMR, and 13C-NMR. Notably, some of these derivatives have exhibited anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv, with minimum inhibitory concentrations (MICs) ranging from 4-16 µg/mL for the most active compounds.

Further research has explored the preparation of new heterocyclic derivatives by treating this compound with aromatic aldehydes to form imine derivatives, which then undergo cycloaddition reactions to produce azetidin-2-one derivatives. ekb.egekb.eg Other synthetic routes include the formation of pyridazine, pyrazolines, and pyrimidine compounds by reacting this compound derivatives with various reagents under ultrasound irradiation. edu.krd These heterocyclic compounds have shown promising antimicrobial activities against human pathogenic bacteria strains like Escherichia coli and Staphylococcus aureus, as well as fungi such as Candida albicans. edu.krd

Schiff Base Derivatives of this compound

Schiff bases, formed by the condensation of an amine with an aldehyde or ketone, represent another significant class of this compound derivatives. A series of (E)-4-(benzylideneamino)-N-(pyrimidin-2-yl)benzenesulfonamide compounds have been synthesized from this compound and substituted aromatic aldehydes. nih.govresearchgate.net These derivatives have been investigated for their urease inhibitory activity, with some compounds demonstrating potent inhibition. For instance, one active compound exhibited an IC₅₀ value of 2.21 ± 0.45 µM against urease, showing significantly higher potency than the standard thiourea (20.03 ± 2.06 µM). nih.gov

Additionally, this compound-salicylaldehyde-based Schiff bases have been synthesized and evaluated for their antimicrobial activity against a broad panel of pathogens, including Gram-positive and Gram-negative bacteria, yeasts, moulds, and mycobacteria. mdpi.com The genus Staphylococcus, including methicillin-resistant S. aureus (MRSA), showed high susceptibility to these derivatives, with MIC values as low as 7.81 µM. mdpi.com

Sulfonamide-Linked Drug Derivatives (e.g., with Ciprofloxacin, Amantadine)

The concept of linking this compound to other established drugs via sulfonamide linkages has been explored to create novel hybrid compounds with potentially enhanced or broader therapeutic profiles. New series of sulfonamide-based drugs have been synthesized by reacting this compound with suitably substituted sulfonyl chlorides to construct sulfonamide linkages. mdpi.com This approach has been applied to versatile drugs such as ciprofloxacin and amantadine, forming sulfonamide-linked derivatives. mdpi.com For this compound, where the amine function is less reactive, reflux conditions in pyridine were necessary for the reaction to proceed smoothly, yielding excellent results. mdpi.com These sulfonamide-linked derivatives have been investigated for their inhibitory activity against enzymes like Jack Bean Urease. mdpi.com

Synergistic Antimicrobial Strategies

Synergistic antimicrobial strategies involve combining this compound with other agents to achieve a greater therapeutic effect than either drug alone, often addressing drug resistance or targeting complex infections.

Combination with Pyrimethamine for Toxoplasmosis Treatment

The combination of this compound and pyrimethamine is considered the gold standard for treating toxoplasmosis, an infection caused by the protozoan parasite Toxoplasma gondii. mdpi.comconsensus.appasm.org This regimen targets the active tachyzoite stage of the infection by inhibiting the folate pathway, which is crucial for DNA synthesis in the parasite. asm.orgnih.gov

Studies in rhesus monkeys with congenital Toxoplasma gondii infection demonstrated the efficacy of this combination. Treatment with pyrimethamine (1 mg/kg/day) and this compound (50 mg/kg/day) orally, supplemented with folinic acid, led to the parasite no longer being detectable in amniotic fluid samples 10 to 13 days after treatment initiation. asm.org Furthermore, T. gondii was not found in neonates at birth in treated groups, unlike in untreated controls. asm.org Both drugs were found to cross the placenta effectively, with concentrations in fetal serum for pyrimethamine ranging from 0.05 to 0.14 µg/ml and for this compound from 1.0 to 5.4 µg/ml. asm.org Pyrimethamine also showed accumulation in brain tissue, with concentrations three to four times higher than in serum, while this compound reached about 30% of its serum concentration in brain tissue. asm.org

In a model of long-term chronic T. gondii infection in C57BL/6 mice, combined this compound-plus-pyrimethamine (S+P) therapy significantly reduced brain cyst load, neuroinflammation, and blood-brain barrier disruption. nih.gov This reduction in parasitic burden and associated inflammatory responses corresponded with the resolution of locomotor alterations, anxiety, and depressive-like behaviors, and partial amelioration of hyperactivity and habituation memory loss. nih.gov

asm.org
DrugSerum Elimination Half-Life (h)Maximum Serum Concentration (µg/ml)Fetal Serum Concentration Range (µg/ml)Brain Tissue Concentration (Relative to Serum)
This compound5.258.71.0 - 5.4~30%
Pyrimethamine44.40.220.05 - 0.143-4 times higher

Antimicrobial Resistance of Sulfadiazine: Mechanisms, Epidemiology, and Mitigation

Mechanisms of Resistance to Sulfonamides

Bacterial resistance to sulfonamides, including sulfadiazine, primarily arises through two main evolutionary pathways: alterations in the drug's target enzyme and the acquisition of alternative, drug-insensitive enzymes via gene transfer.

Alterations in Dihydropteroate Synthetase

Sulfonamides exert their antibacterial effect by competitively inhibiting dihydropteroate synthetase (DHPS), an enzyme encoded by the folP gene biorxiv.orgrupahealth.compatsnap.comfrontiersin.orgnih.govdrugbank.com. DHPS is critical for the condensation of para-aminobenzoic acid (pABA) and 6-hydroxymethyl-7,8-dihydropterin pyrophosphate (DHPP) to produce 7,8-dihydropteroate, a precursor in the folate synthesis pathway biorxiv.orgnih.gov. This compound structurally mimics pABA, thereby binding to the DHPS active site and blocking its natural substrate patsnap.comdrugbank.compatsnap.com.

Resistance through this mechanism typically involves spontaneous mutations within the chromosomal folP gene, leading to amino acid substitutions in the DHPS enzyme biorxiv.orgrupahealth.comfrontiersin.orgnih.govpnas.orgmcmaster.ca. These mutations alter the enzyme's active site, reducing its affinity for sulfonamides while largely preserving its ability to bind to its natural substrate, pABA rupahealth.comfrontiersin.org. This discrimination capacity is achieved by increasing the Michaelis constant (K_M) for sulfonamides biorxiv.orgrupahealth.com. For instance, studies on Staphylococcus aureus DHPS have identified specific mutations like F17L, S18L, T51M, E208K, and KE257_dup that contribute to sulfonamide resistance frontiersin.org. Similarly, in Plasmodium falciparum, amino acid differences in DHPS have been linked to varying levels of sulfadoxine (another sulfonamide) resistance, with K_i values differing by almost three orders of magnitude between sensitive and highly resistant isolates pnas.org. Some resistance-conferring alterations involve insertions, such as a Phe-Gly sequence in certain Sul enzymes, which modifies the pABA-interaction region, leading to a significant (over 1000-fold) loss in sulfonamide binding affinity without compromising the rate of dihydropteroate biosynthesis biorxiv.org.

Horizontal Gene Transfer (HGT) and Mobile Genetic Elements (MGEs)

Horizontal gene transfer (HGT) is a predominant mechanism for the rapid dissemination of sulfonamide resistance among bacterial populations biorxiv.orgrupahealth.comfrontiersin.orgnih.govfrontiersin.orgasm.orgmdpi.comnih.gov. This process involves the transfer of genetic material, including antibiotic resistance genes (ARGs), between unrelated bacteria rupahealth.commdpi.com.

The most well-characterized ARGs conferring sulfonamide resistance are the sul genes (sul1, sul2, sul3, and sul4) rupahealth.comnih.govnih.govfrontiersin.orgd-nb.infoplos.org. These genes encode alternative dihydropteroate synthase enzymes (referred to as Sul enzymes) that are intrinsically insensitive to sulfonamides biorxiv.orgrupahealth.com. The Sul enzymes possess a modified active site that allows them to function efficiently in folate synthesis while being largely unaffected by the presence of sulfonamides biorxiv.orgnih.gov.

A critical factor facilitating HGT is the association of sul genes with mobile genetic elements (MGEs), such as plasmids, transposons, and integrons biorxiv.orgrupahealth.comfrontiersin.orgnih.govfrontiersin.orgasm.orgmdpi.comfrontiersin.orgd-nb.infoplos.orgnih.govmdpi.com. Plasmids, which are extrachromosomal DNA molecules, can be readily transferred between bacterial cells through conjugation, a direct cell-to-cell contact mechanism frontiersin.orgfrontiersin.orgmdpi.comnih.gov. Transposons are DNA sequences that can move to different locations within a genome, and integrons are genetic elements capable of capturing and expressing gene cassettes, often including ARGs asm.orgmdpi.com.

Class 1 integrons, in particular, are frequently found co-locating with sul1 and sul2 genes, significantly contributing to their widespread dissemination in both clinical and environmental settings nih.govasm.orgmdpi.comfrontiersin.orgd-nb.infonih.govasm.org. While sul1, sul2, and sul3 are commonly associated with MGEs, recent research has identified sul4, a newer mobile sulfonamide resistance gene, which in some marine bacterial isolates, was not accompanied by known MGEs, suggesting clonal transfer in those specific cases nih.govfrontiersin.orgd-nb.infodoaj.org. However, sul4 has also been reported in integrons, indicating its potential for broader mobility d-nb.info.

Vertical Gene Transfer

Vertical gene transfer (VGT) refers to the inheritance of genetic material, including resistance genes, from parent bacterial cells to their progeny during cell division rupahealth.comfrontiersin.orgmdpi.com. This mechanism plays a fundamental role in the maintenance and accumulation of resistance within a bacterial lineage once it has acquired resistance determinants, whether through spontaneous mutation or HGT rupahealth.commdpi.com.

Spontaneous mutations in the chromosomal folP gene, which lead to altered DHPS enzymes, are classic examples of resistance arising via VGT rupahealth.commdpi.com. While HGT is a rapid and efficient way for bacteria to acquire novel resistance traits from diverse sources, VGT ensures the perpetuation of these advantageous traits within a population, especially under continued selective pressure from antibiotics. Studies have indicated that while HGT is the primary driver for the dissemination of sul genes, VGT contributes to their stability and persistence within bacterial populations frontiersin.org.

Epidemiology of this compound Resistance

The epidemiology of this compound resistance reflects its long history of use and the selective pressures exerted in both clinical and environmental contexts, leading to its widespread prevalence.

Emergence in Clinical Settings (e.g., Burns Units)

The extensive use of sulfonamides has directly contributed to the significant development of bacterial resistance across various clinical settings rupahealth.com. Burns units, in particular, have historically served as hotspots for the emergence and dissemination of this compound resistance due to the routine application of topical antimicrobial agents like silver this compound for infection prophylaxis and treatment wounds-uk.comnih.govinstitutobeatrizyamada.com.br.

Early observations in burns units noted a substantial increase in the proportion of this compound-resistant Gram-negative bacilli following the introduction of silver this compound cream wounds-uk.comnih.gov. When sulfonamide treatment was discontinued in these wards, the incidence of resistant strains, particularly Klebsiella species, decreased nih.gov. Studies have shown that Staphylococcus aureus and coliforms were frequently isolated from wounds treated with silver this compound, with a high percentage of these isolates exhibiting sulfonamide resistance wounds-uk.com. Furthermore, transferable resistance to this compound has been demonstrated in various species, including Klebsiella sp. and Escherichia coli, isolated from burn patients, highlighting the role of HGT in clinical settings nih.gov.

Table 1: Prevalence of Multidrug-Resistant Organisms in Burn Units (2011-2019) frontiersin.org

PathogenMDR Prevalence in BICU (2011)MDR Prevalence in BICU (2019)MDR Prevalence in BCW (2011)MDR Prevalence in BCW (2019)
Acinetobacter baumannii80.2%92.7%59.7%89.3%
Klebsiella pneumoniae67.7% (in 2015)86.8%40.0% (in 2015)80.7%
Pseudomonas aeruginosa85.7%24.5%23.5%6.9%
MRSA89.5%96.3%62.8%82.9%

Prevalence and Dissemination in Environmental Reservoirs (e.g., Soil, Water, Manure)

Environmental reservoirs play a crucial role in the persistence and dissemination of sulfonamide resistance. Antibiotic resistance genes (ARGs) associated with sulfonamides are widely detected in various environmental matrices, including agricultural soils, water bodies, and animal manure rupahealth.comnih.govfrontiersin.orgplos.orgnih.govmdpi.comasm.orgasm.orgoup.com.

The application of animal manure as fertilizer is a significant contributor to the spread and abundance of ARGs in agricultural soils plos.orgoup.com. Manure from animals treated with sulfonamides, such as this compound, can introduce resistant bacteria and their genes into the environment asm.orgoup.com. Studies in the United Kingdom revealed that phenotypic resistance to sulfachloropyridazine (SCP) was significantly higher in bacterial isolates from pig slurry and post-application soil compared to pre-application soil asm.org.

The sul1, sul2, and sul3 genes are commonly found in manured agricultural soils and pig slurry plos.orgasm.orgasm.org. The prevalence of these sul genes can vary depending on the specific environment and the type of animal manure applied. For instance, in soils from Jiangsu Province, China, the frequency of sul genes in pig-manured soil DNA was sul1 > sul2 > sul3, while in chicken-manured soil DNA, it was sul2 > sul1 > sul3 plos.org.

Table 2: Prevalence of sul Genes in Manured Soil Isolates plos.orgasm.org

sul GenePrevalence in Pig-Manured Soil (UK, n=531 isolates) asm.orgPrevalence in Pig-Manured Soil DNA (China) plos.orgPrevalence in Chicken-Manured Soil DNA (China) plos.org
sul123%HighestSecond Highest
sul218%Second HighestHighest
sul39%LowestLowest
All three2%Not specified (co-presence of sul1+sul2 most frequent)Co-presence of sul1+sul2+sul3 found in chicken farm isolates plos.org

Sulfonamide-resistant pathogens identified in environmental reservoirs include Shigella flexneri, Aerococcus spp., Acinetobacter baumannii, Psychrobacter, Enterococcus, Bacillus spp., and Pseudomonas plos.orgasm.orgasm.org. This highlights the potential for environmental reservoirs to act as sources for human exposure to resistant bacteria.

Wastewater discharge also contributes significantly to the dissemination of sulfonamide resistance. Pharmaceutical wastewaters and municipal wastewater treatment plants (WWTPs) have been shown to contain varying amounts of antibiotics, including this compound, and high prevalences of sul1 and sul2 genes nih.govmdpi.com. Even at low concentrations, antibiotics in wastewater can exert selective pressure, promoting the evolution and spread of ARGs among environmental bacteria and potentially to human pathogens mdpi.com.

Environmental Fate, Ecotoxicology, and Environmental Risk Assessment of Sulfadiazine

Occurrence and Persistence in Aquatic Environments

Sulfadiazine is commonly found in aquatic environments due to its high water solubility and relatively low hydrophobicity, which facilitates its mobility fishersci.befishersci.fifishersci.cawikipedia.org. Conventional wastewater treatment processes are often insufficient for its complete removal, contributing to its environmental presence nih.govwikipedia.org.

Concentrations in Surface and Ground Waters, Wastewater, and Sewage Sludge

This compound and other sulfonamides have been detected in various water compartments and environmental matrices at varying concentrations. In wastewater from treatment plants or animal farms, sulfonamide concentrations typically range from 2 to 60 µg/L wikipedia.org. More specifically for this compound, concentrations of approximately 0.019 µg/L have been detected in processed sewage in Canadian cities, while effluents after secondary treatment in Germany showed detection levels of 0.081 µg/L guidetopharmacology.org.

Surface waters have reported sulfonamide concentrations ranging from 10 ng/L to 1.4 µg/L wikipedia.org. This compound specifically has been found at a maximum concentration of 0.056 µg/L in the surface water of Poyang Lake, China, and at 502.43 ng/L in other surface water samples guidetopharmacology.orgguidetopharmacology.org. In groundwater, sulfonamide concentrations are generally below 10 ng/L wikipedia.org.

In soil matrices, particularly those adjacent to livestock farms, residual this compound concentrations can reach up to 2.45 mg/kg, with other fields showing ranges of 100–1000 µg/kg wikipedia.org. This compound has also been detected in sewage sludge uni.lu.

Table 1: Reported Concentrations of this compound in Environmental Matrices

Environmental MatrixConcentration Range/ValueSource
Wastewater/Animal Farms (Sulfonamides)2–60 µg/L wikipedia.org
Processed Sewage (Canada)~0.019 µg/L guidetopharmacology.org
Wastewater Effluent (Germany, secondary treatment)0.081 µg/L guidetopharmacology.org
Surface Water (Sulfonamides)10 ng/L–1.4 µg/L wikipedia.org
Surface Water (Poyang Lake, China)Max 0.056 µg/L guidetopharmacology.org
Surface Water502.43 ng/L guidetopharmacology.org
Groundwater (Sulfonamides)Below 10 ng/L wikipedia.org
Soil (adjacent to livestock farms)Up to 2.45 mg/kg wikipedia.org
Soil (other fields)100–1000 µg/kg wikipedia.org

Phototransformation Processes and Half-Life in Surface Water

Photolysis is a crucial degradation pathway for this compound in surface waters wikipedia.orgwikipedia.orgwikipedia.org. Studies indicate that direct photolysis is the primary mechanism for this compound photodegradation in ultrapure water wikipedia.org. Several environmental factors can significantly influence the efficiency of this compound phototransformation. Higher pH values, as well as the presence of humic substances, sodium chloride (NaCl), or synthetic sea salts, have been shown to enhance its degradation wikipedia.org.

Under typical surface water conditions, comparable to those found in the Swiss river Thur, the estimated phototransformation half-life for this compound ranges from 3 to 13 days nih.govwikipedia.orgwikipedia.org. In controlled laboratory settings, the half-life in ultrapure water was determined to be 6.76 hours at pH 7.3 and 12.2 hours at pH 6.3 wikipedia.org. Photodegradation was found to be notably faster in environmental matrices such as sewage treatment plant effluent, fresh water, and brackish water, with half-lives ranging between 2.3 and 3.48 hours, compared to ultrapure water wikipedia.org. Mathematical simulations predict that this compound's half-life in natural aqueous systems can vary from less than 2 to approximately 90 days, influenced by water depth and the concentration of key species like dissolved organic carbon (DOC), bicarbonate (HCO3-), and nitrite (NO2-) fishersci.camims.com.

Table 2: Phototransformation Half-Lives of this compound

Environment/ConditionpHHalf-LifeReference
Surface Water (typical conditions)-3–13 days nih.govwikipedia.orgwikipedia.org
Ultrapure Water7.36.76 hours wikipedia.org
Ultrapure Water6.312.2 hours wikipedia.org
Sewage Treatment Plant Effluent-2.3–3.48 hours wikipedia.org
Fresh Water-2.3–3.48 hours wikipedia.org
Brackish Water-2.3–3.48 hours wikipedia.org
Natural Aqueous Systems (predicted)-<2 to ~90 days fishersci.camims.com

Biodegradation in Environmental Matrices

This compound is generally considered not readily biodegradable wikipedia.orgmims.com. In biodegradation experiments, the decrease in this compound concentrations was observed to be minimal, around 4% wikipedia.org. Hydrolytic experiments conducted at typical environmental pH values also indicate its resistance to degradation through hydrolysis wikipedia.org.

Despite its general recalcitrance, specific microbial degradation has been observed under certain conditions. For instance, the bacterium Enterobacter cloacae T2, when immobilized on bagasse, demonstrated a significant degradation potential, achieving 78.19% degradation of this compound in soil under optimal conditions (28 °C and pH 3.5) wikipedia.orgwikipedia.org. Another study reported that Microbacterium lacus strain SDZm4 was capable of completely degrading this compound within 10 days in soil that had been treated with manure containing the antibiotic wikipedia.org.

Ecotoxicological Impact on Aquatic and Terrestrial Organisms

Sulfonamides, including this compound, are ubiquitous in aquatic environments and contribute to ecological risk fishersci.fifishersci.ca. Ecotoxicity bioassays consistently show that algae are the most susceptible aquatic organisms to sulfonamide exposure, followed by crustaceans and fish fishersci.fifishersci.ca.

Effects on Crustaceans (Daphnia magna) and Fish (e.g., Zebrafish)

Effects on Crustaceans (Daphnia magna) this compound exhibits both acute and chronic toxicity to the crustacean Daphnia magna. The LC50 (lethal concentration for 50% of the population) for Daphnia magna exposed to this compound was determined to be 1.884 mg/L fishersci.be. The toxicity of this compound to Daphnia magna is significantly influenced by pH, with higher toxicity observed at lower pH values. The 48-hour EC50 (effective concentration for 50% of the population) values were reported as 27.2 mg/L at pH 6.0, 188 mg/L at pH 7.5, and 310 mg/L at pH 8.5 nih.govnih.govnih.gov. This increased toxicity at lower pH is attributed to a higher fraction of the un-ionized form of this compound, which can more readily permeate cell membranes nih.govnih.gov. For chronic toxicity, the No Observed Effect Concentration (NOEC) for Daphnia magna is 6 mg/L mims.comwikidata.org. Furthermore, the bioconcentration factor (on a dry weight basis) for this compound in Daphnia magna was found to be 50 at pH 6.0 and 36 at pH 8.5 nih.govnih.gov.

Table 3: Toxicity of this compound to Daphnia magna

ParameterValuepHReference
LC501.884 mg/L- fishersci.be
48-h EC5027.2 mg/L6.0 nih.govnih.govnih.gov
48-h EC50188 mg/L7.5 nih.govnih.govnih.gov
48-h EC50310 mg/L8.5 nih.govnih.govnih.gov
NOEC (chronic)6 mg/L- mims.comwikidata.org
Bioconcentration Factor (dry weight)506.0 nih.govnih.gov
Bioconcentration Factor (dry weight)368.5 nih.govnih.gov

Effects on Fish (e.g., Zebrafish) Exposure of fish, such as zebrafish (Danio rerio), to sulfonamides, including this compound, has been linked to various adverse effects. These include an increased heart rate and abnormal swimming behavior fishersci.be. This compound has also been identified as a typical inducer of metabolic enzymes in fish, suggesting a potential ecotoxicological risk fishersci.be. Even at low concentrations, sulfonamides like sulfadimidine (a synonym for sulfamethazine) at 0.001 mg/L have been shown to cause significant toxic effects on the spontaneous movements, heartbeats, and hatching of zebrafish embryos fishersci.cawikidata.org. Furthermore, exposure can lead to characteristic malformations in embryos and larvae, such as pericardial edema, yolk sac edema, hemoglutinations, tail deformation, and swim bladder defects fishersci.cawikidata.org. The No Observed Effect Concentration (NOEC) for chronic toxicity in zebrafish is 0.157 mg/L mims.comwikidata.org.

Table 4: Toxicity of this compound to Zebrafish

ParameterValueEffects ObservedReference
NOEC (chronic)0.157 mg/L- mims.comwikidata.org
Low Concentration (e.g., 0.001 mg/L for sulfadimidine)-Increased heart rate, abnormal swimming, malformations (pericardial edema, yolk sac edema, hemoglutinations, tail deformation, swim bladder defects), effects on spontaneous movements and hatching fishersci.befishersci.cawikidata.org

Pharmacogenomics and Sulfadiazine

Genetic Variability in Drug Response

Genetic variability plays a crucial role in determining how individuals respond to pharmaceutical agents. This variability can impact various pharmacokinetic and pharmacodynamic processes, including drug absorption, distribution, metabolism, elimination, and interaction with drug targets or downstream regulatory mechanisms. nih.govuni.lu

One significant area of pharmacogenetic influence on sulfadiazine involves its metabolism, particularly through acetylation. Studies have demonstrated that the rate of this compound elimination, primarily via acetylation, is under genetic control. Research conducted in rabbits, for instance, confirmed that rapid elimination is a dominant genetic trait over slow elimination of the drug. wikidata.orgciteab.com

Further research has explored the impact of other metabolic factors on this compound pharmacokinetics in individuals with varying acetylation phenotypes. For example, the influence of pyruvic acid on this compound pharmacokinetics has been observed in slow acetylators. In these individuals, the presence of pyruvic acid led to a notable decrease in the drug's beta half-life and area under the curve (AUC), alongside an increase in its clearance and elimination rate constant (k10). citeab.com These findings highlight the complex interplay between genetic factors and endogenous metabolites in modulating drug disposition.

Table 1: Impact of Pyruvic Acid on this compound Pharmacokinetics in Slow Acetylator Rabbits

Pharmacokinetic ParameterWithout Pyruvic Acid (Mean ± SD)With Pyruvic Acid (Mean ± SD)p-value
Beta Half-life (min)115.74 ± 12.4762.96 ± 4.36< 0.001
AUC (µg min mL⁻¹)10,617.38 ± 1179.816217.14 ± 391.32< 0.001
Clearance (L min⁻¹ kg⁻¹)0.0044 ± 0.00080.0068 ± 0.0007< 0.001
k10 (min⁻¹)0.0090 ± 0.00090.0193 ± 0.0028< 0.005

Note: In an interactive environment, this table could be sorted by any column to facilitate data analysis.

Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and this compound

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common X-linked recessive enzymatic disorder affecting hundreds of millions globally. wikidata.orgmims.com The G6PD enzyme is critical for maintaining adequate levels of nicotinamide adenine dinucleotide phosphate (NADPH) in red blood cells, which in turn protects them from oxidative damage by maintaining glutathione levels. A deficiency in G6PD renders red blood cells vulnerable to oxidative stress, leading to hemolysis. wikidata.org

Sulfonamides, including this compound, are recognized as agents that can precipitate hemolytic crises in individuals with G6PD deficiency. wikidata.orgfishersci.atnih.govnih.govuni.lu Regulatory bodies, such as the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) and Health Canada (HCSC), advise caution when this compound is administered to patients with G6PD deficiency due to the potential for hemolysis. nih.govnih.gov

Despite the general caution associated with sulfonamides, some studies specifically on this compound have indicated that it may not be hemolytic in many G6PD-deficient individuals, and some research has reported its safe use in deficient infants. wikidata.orgfishersci.atmims.com However, cases of hemolysis triggered by topical silver this compound, particularly when absorbed through burn wounds, have been documented in G6PD-deficient children, underscoring the importance of considering the route of administration and patient-specific factors. mims.commpg.de

Research Frontiers in this compound Pharmacogenomics

The ongoing advancements in pharmacogenomics are paving the way for a more precise understanding of drug responses, including for compounds like this compound. Research frontiers in this area are focused on leveraging genomic information to personalize drug therapy and enhance patient safety. uni.lu

Key areas of current and future research in pharmacogenomics relevant to this compound include:

Advanced Genomic Technologies: The field is transitioning from targeted genotyping to more comprehensive sequencing-based pharmacogenomics, which allows for the detection of a broader spectrum of genetic variations, including rare variants. guidetopharmacology.org

Understanding Non-Coding Variants: Future research aims to improve the understanding of the impact of non-coding genetic variants on drug response, which may reveal novel mechanisms influencing this compound's pharmacokinetics or pharmacodynamics. guidetopharmacology.org

Functional Genomics: Large-scale functional genomics studies are being employed to characterize the effects of rare genetic variants, providing deeper insights into how specific genetic changes translate into altered drug responses. guidetopharmacology.org

Polygenic Risk and Combinatorial Approaches: There is a growing interest in exploring polygenic risk scores and combinatorial approaches, which consider the cumulative effect of multiple genetic variants on drug response, rather than focusing on single gene-drug interactions. guidetopharmacology.org

Identification of Key Pharmacogenes: Efforts are underway to identify pharmacogenes with strong evidence-based associations with drug response alterations, such as CYP2D6, CYP2C9, CYP2C19, G6PD, HLA-B, and SLCO1B1. This prioritization helps in developing and implementing pharmacogenomic guidelines and gene panels for clinical testing. nih.gov

Genetic Influences on Hypersensitivity: Further investigation into the genetic basis of sulfonamide-induced hypersensitivity reactions is an active area of research. Specific human leukocyte antigen (HLA) genes, including HLA-A29, HLA-B12, HLA-DR7, HLA-B44, HLA A11:01, HLA-A30 B13 Cw6 haplotype, and HLA-B1502, have been associated with these reactions and warrant further study to elucidate underlying mechanisms.

Replication in Diverse Populations: For pharmacogenomic findings to be widely applicable, it is crucial to replicate genetic marker associations with drug response in diverse populations, accounting for varying genetic backgrounds across racial and ethnic groups.

These research directions aim to integrate genetic information more effectively into clinical practice, ultimately leading to more personalized and safer therapeutic strategies involving drugs like this compound.

Emerging Research Directions and Future Perspectives on Sulfadiazine

Novel Synthetic Routes and Derivatization for Enhanced Bioactivity

Research into sulfadiazine is actively pursuing novel synthetic routes and derivatization strategies to enhance its bioactivity, aiming for improved efficacy and broader therapeutic applications. Microwave-assisted synthesis has emerged as an efficient method for producing new this compound-imine derivatives, such as A1 and A2. These derivatives have demonstrated significantly improved antibacterial activities against various strains, including Bacillus subtilis, Streptococcus pneumoniae, and Escherichia coli, compared to the parent this compound arikesi.or.idresearchgate.netarikesi.or.id. The enhanced properties are attributed to increased lipophilicity and improved cellular penetration conferred by the imine functional group arikesi.or.idresearchgate.netarikesi.or.id.

Beyond antibacterial effects, derivatization has also yielded compounds with potent anticancer properties. For instance, diazotization of this compound with active methylene compounds has led to derivatives (e.g., compounds 8, 12, and 14) exhibiting strong antiproliferative activity against cancer cell lines such as A431, A549, and H1975. Notably, these derivatives have shown lower IC50 values than established epidermal growth factor receptor (EGFR) inhibitors like erlotinib, gefitinib, and osimertinib, indicating their potential as novel anticancer agents rsc.orgrsc.org.

Furthermore, new bioprecursor prodrugs of this compound have been synthesized and characterized, with the aim of developing selective drug delivery systems where the active drug is released by bacterium-specific enzymes at the infection site mdpi.com. Schiff bases derived from this compound and various salicylaldehydes have also been reported to possess antifungal and antimycobacterial properties, with halogen groups playing a significant role in their enhanced activity researchgate.net. Similarly, novel azo-azomethine compounds synthesized from this compound have been screened for their antimicrobial and antioxidant potential ekb.eg.

The following table summarizes selected novel this compound derivatives and their enhanced bioactivities:

Derivative Type / CompoundSynthesis MethodEnhanced BioactivityKey FindingsReference
This compound-imine (A1, A2)Microwave-assistedAntibacterial, AnticancerIncreased lipophilicity and cellular penetration; A1 showed highest efficacy against B. subtilis, S. pneumoniae, E. coli; dose-dependent cytotoxicity against MCF-7 breast cancer cells. arikesi.or.idresearchgate.netarikesi.or.id
This compound derivatives (e.g., 8, 12, 14)Diazotization with active methylene compoundsAnticancer (antiproliferative)Potent activity against A431, A549, H1975 cancer cell lines; lower IC50 values than erlotinib, gefitinib, osimertinib; compound 12 most potent EGFRWT and EGFRT790M inhibitor. rsc.orgrsc.org
Bioprecursor prodrugsCoupling of diazonium salt, cyclocondensationTargeted drug deliveryDesigned for bacterium-specific enzyme release at infection sites. mdpi.com
Schiff basesReaction with salicylaldehydesAntifungal, AntimycobacterialHalogen groups crucial for activity. researchgate.net
Azo-azomethine compoundsCoupling of this compound diazonium saltAntimicrobial, AntioxidantBroad-spectrum activity against bacteria and fungi. ekb.eg

Advanced Computational Studies (e.g., Molecular Docking, Molecular Dynamics Simulations, QSAR)

Advanced computational techniques are increasingly employed in this compound research to elucidate its molecular interactions, predict biological activities, and guide the design of new derivatives. These methods include molecular docking, molecular dynamics (MD) simulations, and Quantitative Structure-Activity Relationship (QSAR) studies mdpi.comijpsr.comtubitak.gov.trmdpi.comnih.govnih.govresearchgate.netsemanticscholar.orgmdpi.comresearchgate.netresearchgate.netnih.gov.

Molecular docking studies have been instrumental in understanding this compound's binding interactions with various enzymatic targets. For instance, investigations into its anticancer potential have revealed key binding interactions with cyclooxygenase (COX) and lipoxygenase (LOX) enzymes. This compound has shown a balanced inhibitory activity against the 5-LOX/COX-1 enzymes, suggesting its role as a potential anticancer agent by modulating the COX/LOX pathway and reducing inflammatory gene expression researchgate.netmdpi.comnih.govdntb.gov.ua.

Molecular dynamics simulations are utilized to assess the stability and endurance of ligand-protein complexes. These simulations have been conducted to verify docking validations and the stability of this compound and its derivatives when bound to target proteins, including those of the White Spot Syndrome Virus (WSSV) in shrimp mdpi.comnih.govmdpi.comresearchgate.net. The root mean square deviation (RMSD) and root mean square fluctuation (RMSF) analyses from MD simulations provide insights into the dynamic behavior and binding stability of these complexes mdpi.comnih.govresearchgate.net.

QSAR studies aim to establish mathematical relationships between chemical structures and biological activities, facilitating the prediction of activity for new compounds. QSAR models have been developed for this compound-salicylaldehyde Schiff base analogues to predict their anti-mycobacterial activity, helping to design more potent agents ijpsr.com. Furthermore, pharmacophore mapping combined with QSAR has been used to generate novel pyrimidine derivatives as DNA inhibitors for cancer treatment, with subsequent ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) screening to assess their drug-likeness researchgate.net.

Computational approaches also extend to environmental studies. Molecular dynamics simulations combined with quantum chemistry calculations have been used to investigate the pH-dependent interactions of this compound with soil particle models, such as silica. These studies provide valuable insights into the adsorption mechanisms and potential for aggregation of this compound molecules on soil surfaces, which is crucial for understanding its environmental fate and transport nih.gov.

The following table highlights examples of advanced computational studies involving this compound:

Computational MethodTarget/ApplicationKey Insight/OutcomeReference
Molecular DockingCOX/LOX enzymes (anticancer)Balanced inhibitory activity against 5-LOX/COX-1; potential anticancer agent. researchgate.netmdpi.comnih.govdntb.gov.ua
Molecular Dynamics SimulationsWSSV proteins (antiviral), COX/LOX enzymesVerified docking stability and endurance of this compound-protein complexes; assessed binding stability. mdpi.commdpi.comnih.govmdpi.comresearchgate.net
QSAR StudiesThis compound-salicylaldehyde Schiff bases (anti-mycobacterial)Developed pharmacophoric models for predicting anti-mycobacterial activity. ijpsr.com
QSAR & Pharmacophore MappingPyrimidine derivatives (DNA inhibitors for cancer)Generated novel chemical entities with potential anticancer activity; ADMET screening for drug-likeness. researchgate.net
DFT, NBO, Hirshfeld AnalysisThis compound and its adducts (e.g., with cysteine)Analyzed geometrical parameters, electron densities, UV-Vis spectra, and intermolecular interactions. mdpi.comtubitak.gov.trsemanticscholar.org
Molecular Dynamics & Quantum ChemistrySoil particle models (environmental fate)Investigated pH-dependent interactions and aggregation potential on soil surfaces. nih.gov

Repurposing for Non-Antimicrobial Applications (e.g., Anticancer, Antiviral)

Beyond its established role as an antimicrobial agent, this compound is being explored for repurposing in various non-antimicrobial therapeutic areas, particularly in oncology and virology, leveraging its diverse biological activities.

Anticancer Applications: this compound and its derivatives have shown promising anticancer effects. This compound itself has demonstrated potential anticancer activity in human hepatocellular carcinoma (HepG2) and breast cancer (MCF7) cell lines by inhibiting the expression of inflammatory genes and mediators, including TNFα, IL1b, COX-1, COX-2, and 5-LOX researchgate.netmdpi.comnih.govdntb.gov.ua. This suggests a mechanism involving the modulation of inflammatory pathways crucial for cancer progression.

Novel this compound-imine derivatives have exhibited dose-dependent cytotoxicity against MCF-7 breast cancer cells, with derivative A1 showing a significant reduction in cell viability arikesi.or.idresearchgate.netarikesi.or.id. Furthermore, this compound has been utilized as a targeting ligand in drug delivery systems. For example, this compound-decorated poly(lactide-co-glycolide) (PLGA) nanoparticles loaded with 5-fluorouracil (5-FU) have shown enhanced cytotoxicity against cancer cells like A431 and Caco-2. This enhancement is attributed to this compound's reported capacity to concentrate in tumor cells, leading to improved therapeutic efficiency mdpi.com. Sulfonamide derivatives, including those derived from this compound, are recognized for their potent growth inhibitory activity against a range of tumor lines and tyrosine kinase enzymes, acting through various mechanisms such as inhibition of carbonic anhydrase, matrix metalloproteinase, and perturbation of the cell cycle rsc.orgmdpi.comresearchgate.net.

Antiviral Applications: While this compound itself typically lacks antiviral activity, its silver salt, silver this compound (SSD), has demonstrated in vitro antiviral effects. SSD has been shown to inhibit Herpesvirus hominis types 1 and 2, with the antiviral effect directly related to the drug's concentration and exposure duration wounds-uk.comdovepress.comnih.govoup.com. This activity is primarily attributed to the silver moiety, which is believed to interfere with viral envelope integrity wounds-uk.comoup.com. Additionally, certain 1,3-diaryltriazene-substituted this compound derivatives have exhibited higher antiviral activity than this compound against Modified Vaccinia Virus Ankara, indicating the potential for derivatization to unlock new antiviral properties researchgate.net.

Anti-inflammatory Effects: Beyond its direct antimicrobial and anticancer roles, this compound also possesses anti-inflammatory properties. Studies have shown its capacity to suppress the inflammatory response at a molecular level by affecting key inflammatory mediators such as TNFα, IL1b, and the enzymes COX-1, COX-2, and 5-LOX mdpi.comnih.govdntb.gov.ua. Silver this compound, in particular, has been observed to reduce ischemia and inflammation in burn wounds, modulating the inflammatory response and contributing to wound healing oup.comjddtonline.infobiolifesas.org.

The following table summarizes the non-antimicrobial applications of this compound and its derivatives:

Application AreaKey Findings / MechanismRelated CompoundsReference
Anticancer Inhibits TNFα, IL1b, COX-1, COX-2, 5-LOX gene expression; causes dose-dependent cytotoxicity; enhances activity of other anticancer drugs by concentrating in tumor cells; inhibits tyrosine kinase enzymes.This compound, this compound-imine derivatives (A1, A2), this compound-decorated PLGA nanoparticles (with 5-FU), this compound derivatives (e.g., 8, 12, 14). arikesi.or.idresearchgate.netarikesi.or.idrsc.orgrsc.orgmdpi.comnih.govdntb.gov.uamdpi.comresearchgate.net
Antiviral Inhibits Herpesvirus hominis types 1 and 2 (attributed to silver moiety); certain derivatives show enhanced antiviral activity.Silver this compound (SSD), 1,3-diaryltriazene-substituted this compound derivatives. wounds-uk.comdovepress.comnih.govoup.comresearchgate.net
Anti-inflammatory Suppresses inflammatory mediators (TNFα, IL1b, COX-1, COX-2, 5-LOX); reduces ischemia and inflammation in burn wounds.This compound, Silver this compound (SSD). mdpi.comnih.govdntb.gov.uaoup.comjddtonline.infobiolifesas.org

Interdisciplinary Research on Environmental Antimicrobial Resistance (AMR)

Interdisciplinary research is crucial for understanding and mitigating the environmental dimensions of antimicrobial resistance (AMR), with this compound being a significant focus due to its widespread use in human and veterinary medicine. The presence of this compound in the environment contributes to the emergence and dissemination of sulfonamide-resistant bacteria and antibiotic resistance genes (ARGs) mdpi.comnih.govfrontiersin.orgresearchgate.netasm.orgfrontiersin.org.

This compound, along with other antibiotics, frequently enters the environment through various pathways, including agricultural runoff, leaching from treated effluent, and the application of animal manure mdpi.comnih.gov. Studies have shown that this compound residues can persist in aquatic environments and sediments, acting as a selective pressure for resistant bacterial populations mdpi.com. In agricultural settings, repeated application of pig manure containing this compound has been linked to a significant increase and accumulation of sulfonamide resistance genes, specifically sul1 and sul2, in arable soils researchgate.netasm.org. These ARGs are often found on mobile genetic elements (MGEs), such as plasmids, which facilitates their horizontal gene transfer (HGT) among diverse microbial communities, thereby accelerating the spread of multidrug resistance nih.govresearchgate.netasm.org.

Even at low concentrations, this compound can influence various soil microbial processes and alter the composition and diversity of microbial communities frontiersin.org. Computational studies, including molecular dynamics simulations and quantum chemistry calculations, are being employed to investigate the environmental fate of this compound, such as its pH-dependent interactions and aggregation potential on soil particle models. Such studies are vital for predicting and controlling the migration and transformation of sulfonamide antibiotics in the soil environment nih.gov.

Furthermore, the transformation products of this compound in the aquatic environment can also pose a risk of inducing resistance development, highlighting the complexity of environmental AMR and the need to consider metabolites in risk assessments acs.org. Research using mouse models has shown that exposure to clinical concentrations of this compound can lead to spatially and temporally confined increases in gastrointestinal AMR, underscoring the direct link between antibiotic exposure and resistance development in biological systems mdpi.comnih.gov.

The following table summarizes the environmental impacts of this compound related to AMR:

Environmental CompartmentImpact on AMRKey FindingsReference
Aquaculture/Water Bodies Emergence of sulfonamide-resistant bacteria; persistence of residues.Use in aquaculture contributes to resistance in fish and aquatic environments; residues remain in water/sediment, promoting AMR. mdpi.com
Soil Accumulation of ARGs (sul1, sul2); selection pressure on microbial communities.Repeated manure application with this compound increases ARGs; even low concentrations affect soil microbial processes and diversity. nih.govfrontiersin.orgresearchgate.netasm.org
Microbial Communities Horizontal gene transfer; spread of multidrug resistance.ARGs associated with this compound are often on mobile genetic elements, facilitating transfer. nih.govresearchgate.netasm.org
Biological Systems (e.g., GI tract) Increased ARG levels.Exposure to this compound leads to confined increases in gastrointestinal AMR. mdpi.comnih.gov
Transformation Products Risk of inducing resistance.Metabolites of this compound can also contribute to AMR development. acs.org

One Health Approach in this compound Research

The "One Health" approach, which recognizes the intrinsic interconnectedness of human, animal, and environmental health, is increasingly central to this compound research, particularly in the context of antimicrobial resistance. This integrated perspective is crucial for developing comprehensive strategies to combat AMR, as the use and fate of this compound in one domain directly impact the others.

This compound's extensive use in veterinary medicine, especially in livestock and aquaculture, creates a direct link between animal health practices and environmental contamination mdpi.comnih.govnih.gov. For instance, the excretion of this compound by treated animals leads to its presence in manure, which, when applied to agricultural lands, introduces both the antibiotic and associated ARGs into soil ecosystems nih.govasm.org. This environmental presence then acts as a selective pressure, fostering the development and spread of resistant bacteria and genes that can potentially transfer to human pathogens mdpi.comresearchgate.netasm.orgfrontiersin.org.

Research within the One Health framework investigates the entire lifecycle of this compound, from its administration in animals to its environmental persistence and the subsequent impact on human health. This includes monitoring this compound residues in animal excreta, water bodies, and soil, as well as tracking the prevalence and mobility of sulfonamide resistance genes (sul1, sul2) across these compartments mdpi.comnih.govresearchgate.netasm.orgfrontiersin.org. Understanding the environmental fate of this compound and its effects on diverse microbial communities is paramount for mitigating AMR risks across the human-animal-environment interface nih.govfrontiersin.org.

Furthermore, the One Health approach informs policy and regulatory efforts. The AMR Industry Alliance, for example, has developed Predicted No-Effect Concentrations (PNECs) for antibiotics like this compound to guide discharge targets in manufacturing. These science-driven targets aim to protect ecological resources and reduce the potential for AMR evolution in the environment, thereby contributing to global health security amrindustryalliance.org. By integrating insights from veterinary medicine, environmental science, microbiology, and public health, One Health research on this compound provides a holistic understanding necessary for effective AMR containment strategies.

Q & A

How can the FINER criteria improve the formulation of this compound-related research questions?

  • Methodological Answer : Evaluate feasibility by aligning with available analytical tools (e.g., LC-MS/MS for metabolite detection). Ensure novelty by conducting a scoping review of PubMed/MEDLINE (2015–2025). Address relevance through alignment with WHO priority pathogens (e.g., ESKAPE organisms) .

Q. What systematic review protocols are recommended for synthesizing this compound’s off-label uses?

  • Methodological Answer : Follow PRISMA guidelines, define PICO criteria (Population: Immunocompromised patients; Intervention: this compound; Comparison: Standard care; Outcome: Infection resolution). Extract data into standardized templates and assess bias via ROBINS-I tool. Register the protocol on PROSPERO .

Retrosynthesis Analysis

AI-Powered Synthesis Planning: Our tool employs the Template_relevance Pistachio, Template_relevance Bkms_metabolic, Template_relevance Pistachio_ringbreaker, Template_relevance Reaxys, Template_relevance Reaxys_biocatalysis model, leveraging a vast database of chemical reactions to predict feasible synthetic routes.

One-Step Synthesis Focus: Specifically designed for one-step synthesis, it provides concise and direct routes for your target compounds, streamlining the synthesis process.

Accurate Predictions: Utilizing the extensive PISTACHIO, BKMS_METABOLIC, PISTACHIO_RINGBREAKER, REAXYS, REAXYS_BIOCATALYSIS database, our tool offers high-accuracy predictions, reflecting the latest in chemical research and data.

Strategy Settings

Precursor scoring Relevance Heuristic
Min. plausibility 0.01
Model Template_relevance
Template Set Pistachio/Bkms_metabolic/Pistachio_ringbreaker/Reaxys/Reaxys_biocatalysis
Top-N result to add to graph 6

Feasible Synthetic Routes

Reactant of Route 1
Sulfadiazine
Reactant of Route 2
Reactant of Route 2
Sulfadiazine

Disclaimer and Information on In-Vitro Research Products

Please be aware that all articles and product information presented on BenchChem are intended solely for informational purposes. The products available for purchase on BenchChem are specifically designed for in-vitro studies, which are conducted outside of living organisms. In-vitro studies, derived from the Latin term "in glass," involve experiments performed in controlled laboratory settings using cells or tissues. It is important to note that these products are not categorized as medicines or drugs, and they have not received approval from the FDA for the prevention, treatment, or cure of any medical condition, ailment, or disease. We must emphasize that any form of bodily introduction of these products into humans or animals is strictly prohibited by law. It is essential to adhere to these guidelines to ensure compliance with legal and ethical standards in research and experimentation.